NetworkNewsBreaks – Avricore Health Inc.’s (TS
Post# of 61
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers in pharmacies. Shortly thereafter, Avricore also entered an agreement with Shoppers Drug Mart to stock HealthTab for diabetes screening in 11 different locations. “The company has recognized an opportunity and capitalizes on established consumer trends, technology advancements, health policy and industry changes to solve a business headache while also meeting a significant market opportunity. All this is built on the company’s HealthTab platform,” reads a recent article. “So far, HealthTab can check up to 27 health markers, screen diabetes and conduct rapid Covid-19 testing. It also offers convenience, with analyses taking less than 10 minutes…. The milestones achieved with HealthTab so far are significant. More so, they highlight the endless possibilities that the platform has regarding the diagnosis of various chronic diseases, bacteria and viruses.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer